Caleb Rans

In boys but not girls, reduced sleep duration at age 8 and 10 years predicted the development of behavioral disorder symptoms 2 years later.

Symptom reduction was significantly correlated with poor metabolic adverse effects, including weight gain, elevated BMI, and higher total cholesterol.

Researchers conducted a case-control study to examine the associations between polygenic risk scores for schizophrenia and other mental disorders with the development of cannabis use disorder.

The researchers analyzed data from 1649 combat-exposed United States military veterans who were evaluated at a Veterans Affairs facility between 2009 and 2012 after deployment to the wars in Iraq and/or Afghanistan.

Researchers sought to address the possible link between cognitive or mood symptoms and statins.

The researchers found that adults with ASD showed significant impairments in both objective (10 of 17 total outcomes) and subjective (6 of 11 total outcomes) measures of sleep compared with controls.

Overall, no significant relationships between task performance and gray matter volume were observed in the clinical high-risk group.

Comorbid anxiety worsened depressive symptom severity in general and was linked to suicidality.

The study emphasizes the necessity of further research concerning a treatment that is increasingly being legalized and applied to a wide range of medical conditions.

Researchers conducted a multicenter randomized controlled trial of 214 veterans with PTSD from January 2012 through September 2013.